[144] Alignment Healthcare, Inc. SEC Filing
Alignment Healthcare, Inc. (ALHC) Form 144 notice reports a proposed sale of 25,000 common shares through broker Justin Tabit, with an aggregate market value of $423,750.00. The filing states the issuer has 198,031,417 shares outstanding and lists an approximate sale date of 09/09/2025 on NASDAQ. The securities were acquired on 10/06/2014 as a stock bonus from Joseph Konowiecki, and the original acquisition record shows 323,139 shares acquired with payment characterized as compensation. The filing also discloses a sale during the past three months: 25,000 shares sold on 07/31/2025 for gross proceeds of $398,750.00 by Joseph Konowi.
- None.
- None.
Insights
TL;DR: This Form 144 is a routine insider sale notice showing proposed and recent dispositions totaling 25,000 shares.
The filing provides required disclosure for a proposed sale under Rule 144: quantity, market value, acquisition details and prior sale within three months. Key compliance items are present: broker name, nature of acquisition (stock bonus), acquisition date, and recent sale record. The document does not include contrary material nonpublic information and contains the standard attestation language. From a regulatory perspective, the filing appears to meet Rule 144 reporting elements contained in the submission.
TL;DR: Insider selling activity disclosed but size is small relative to outstanding shares, suggesting limited direct impact on share supply.
The proposed sale of 25,000 shares equals roughly 0.0126% of the 198,031,417 shares outstanding, indicating the transaction is immaterial to total float. The filing also notes an earlier 25,000-share sale on 07/31/2025 for $398,750, showing consistent disposal activity by the same related party. The document lacks commentary on motive or any linked corporate events; therefore, market implications should be judged in broader context beyond this notice.